Searched for
NPPA
NPPA caps trade margins on 137 cancer drugs at 30%, revised prices from Nov 9India's National Pharmaceutical Pricing Authority has capped trade margins for 137 anti-cancer drugs at 30% of their maximum retail price. ...- Panel to finalise cancer drugs for 30% trade margin cap; Rs 2,500 crore annual savings possibleAn expert group is finalizing the list of cancer medicines for a new trade margin cap. The government plans to implement a 30% cap to reduc...
- Cancer drugs may get up to 70% cheaper as govt fixes trade margins on non-scheduled medicines at 30%The government is aiming to cap trade margins on anti-cancer medications at 30%. An expert committee has been tasked with compiling a repor...
- Govt set to cap trade margins on more cancer drugs before SC hearingThe Indian government plans to announce a new list of cancer drugs for trade margin rationalisation today. Union Health Minister JP Nadda w...
- Karnataka flags 52x mark-up on cancer drugs, seeks Centre's interventionKarnataka conducted inspections revealing significant price disparities between hospital procurement and patient billing for cancer drugs a...
- In healthcare, the patient is the least informed consumerSignificant price differences in healthcare consumables have drawn attention, prompting calls for better consumer protection. Maharashtra's...
- 'Inflated medicine prices are daylight robbery': SC pulls up pharma companies over huge MRP-PTR gapSupreme Court on Tuesday questioned the wide gap between the price to retailer and MRP of some cancer medicines, calling inflated pricing a...
- Hospitals seek new pricing rules as Maharashtra FDA flags high markupsThe healthcare industry seeks a differentiated framework for medical device pricing reviews. Hospitals incur significant costs beyond procu...
- Centre seeks NPPA report on high markups in hospital consumablesThe Centre has requested a report from the NPPA regarding price discrepancies. Maharashtra FDA flagged significant gaps between trade price...
- Rs 11 IV for Rs 325, Rs 6 syringe for Rs 57: Tukaram Mundhe flags 2,841% inflated hospital bills that patients don't even know, sends recommendation to CentreMaharashtra FDA Commissioner Tukaram Mundhe has cited a survey showing substantial differences between procurement prices and printed MRPs ...
- Drug cos refuse to take sole responsibility for overpricingIndian drugmakers oppose a proposal making them solely liable for medicine overpricing. This regulatory move exempts retail chemists, hospi...
- Cipla Pharma license cancellation: FDA withdraws order after HC raps it for going 'overboard'Maharashtra FDA withdrew its order to cancel Cipla Pharma's drug sale license after court intervention. The Bombay High Court criticized th...
- Drugmakers may bear sole responsibility for overpricing essential medicines under NPPA proposalThe National Pharmaceutical Pricing Authority aims to hold drug manufacturers solely accountable for the excessive pricing of essential med...
- FOPE urges pause on NPPA notice, citing potential losses for pharma industryFOPE said that the manufactures follow the rules as laid down in the DPCO, 2013. At the same time, manufacturers look to NPPA to fix the pr...
- Private hospitals making up to 1,737% profit on drugs, finds NPPA studyNPPA's study found that "the major beneficiaries of profits in all these cases because of inflated MRPs have been hospitals rather than dru...
- NPPA fixes retail price of 30 drug formulationsThe National Pharmaceutical Pricing Authority (NPPA) has also revised the prices of three formulations, including that of anti cancer drug ...
- No plans to revamp NPPA: GovernmentIn a written reply to a question in the Rajya Sabha, Minister of State for Chemicals and Fertilisers Mansukh L Mandaviya said the governmen...
- NPPA may lose absolute power to fix drug prices under new policyNPPA presently functions as an autonomous body that regulates prices of medicines under National List of Essential Medicines and monitors p...
- Hospitals can't refuse to sell patients the stents they demand: NPPAIn case of non-compliance of NPPA's instructions, the regulator said it may be constrained to invoke provisions of legal prosecution under ...
- Prices of around 12,000 drug SKUs decline in January: NPPAPrices of around 12,000 stock keeping units (SKUs) of medicines have come down during January this year as a consequence of implementation ...
Load More
